We’ve made it easier for you to access information and share content about biotechnology and prescription medicines. Click on or flip over any of the cards below to learn more about a topic. The information you discover can easily be shared on Twitter, Facebook and LinkedIn.
The Rare Pediatric Disease Priority Review Program (RPD PRV) was established to incentivize the development of therapies to treat rare pediatric diseases. The RPD PRV achieves this goal by granting a priority review voucher to a drug developer who develops and gains approval for a therapy that treats a rare pediatric disease.
Animal biotechnology has enormous potential to address several agricultural, environmental, humanitarian, and public health challenges. In order for these solutions to be realized, the U.S. must act now and develop a sensible, science-based regulatory approval process that provides these technologies with a viable path to market.
First introduced in the Farm Security and Rural Investment Act of 2002, the Farm Bill’s energy title programs support investment in and adoption of renewable energy, renewable chemicals and energy efficiency technologies through research, consumer education, market development programs, and financial grants and loan guarantees.
Gene Therapy. Immunotherapy. Precision Medicine. We’ve come too far to let government mandates, even harmless sounding ones, threaten progress in biomedical research.
The Power of Innovation in Addressing the Opioid Epidemic